Assenagon Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Assenagon Asset Management’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$533K	Sell	21,052 -57,075	-73%	-$1.26M	﹤0.01%	1064
2026 Q1	$1.74M	Buy	78,127 +69,411	+796%	+$1.66M	﹤0.01%	796
2025 Q4	$233K	Sell	8,716 -18,900	-68%	-$452K	﹤0.01%	1110
2025 Q3	$589K	Sell	27,616 -1,683,979	-98%	-$39.8M	﹤0.01%	1027
2025 Q2	$36.9M	Sell	1,711,595 -1,951,550	-53%	-$36.3M	0.05%	263
2025 Q1	$60.8M	Buy	+3,663,145	New	+$66.5M	0.1%	179
2022 Q3	–	Sell	-119,648	Closed	-$1.69M	–	1323
2022 Q2	$1.69M	Sell	119,648 -28,965	-19%	-$541K	0.01%	895
2022 Q1	$3.6M	Buy	148,613 +47,464	+47%	+$1.15M	0.01%	624
2021 Q4	$2.36M	Buy	101,149 +86,934	+612%	+$1.75M	0.01%	761
2021 Q3	$236K	Buy	+14,215	New	+$274K	﹤0.01%	1208
2019 Q4	–	Sell	-19,822	Closed	-$713K	–	744
2019 Q3	$713K	Buy	+19,822	New	+$601K	﹤0.01%	628

Other funds holding ACAD

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $5.7B AUM 35.76% 1-Year Est. Return

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Assenagon Asset Management's ACAD Position: Q2 2026 in Review

Assenagon Asset Management reduced its Acadia Pharmaceuticals (ACAD) stake by 73% in Q2 2026, selling an estimated $1.26M and leaving 21,052 shares worth $533K. The position accounts for ﹤0.01% of the portfolio, ranked #1064.

Assenagon Asset Management first reported a position in ACAD in Q3 2019 and has held it in 11 quarters since. The position peaked at $60.8M in Q1 2025. 35 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

Assenagon Asset Management held 21,052 shares of Acadia Pharmaceuticals worth $533K as of Q2 2026.
Assenagon Asset Management sold 57,075 Acadia Pharmaceuticals shares in Q2 2026, an estimated $1.26M.
Acadia Pharmaceuticals made up ﹤0.01% of Assenagon Asset Management's portfolio in Q2 2026, its #1064 holding.
Assenagon Asset Management first reported a position in Acadia Pharmaceuticals in Q3 2019 and has held it in 11 quarters since.
Assenagon Asset Management's Acadia Pharmaceuticals position peaked at $60.8M in Q1 2025.
35 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.